ATRA
ATRA
NASDAQ · Biotechnology

Atara Biotherapeutics Inc

$4.32
-0.27 (-5.88%)
As of Mar 30, 10:11 PM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 7 64%
Hold 3 27%
Sell 1 9%
Price Target
Analyst Price Target +63.0% upside
Low Target $5.84
Average Target $7.04
High Target $9.41
Current Price $4.32
Current
$4.32
Target
$7.04
$5.84 $7.04 avg $9.41
Scenario Analysis
Bear Case
$5.84
35.2%
Low target
Base Case
$7.04
+63.0%
Avg target
Bull Case
$9.41
+117.8%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$19.15
-77.4% from high
52-Week Low
$3.92
+10.2% from low
Target vs 52W High
$7.04
-63.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%